StockSelector.com
  Research, Select, & Monitor Sunday, July 05, 2020 6:44:20 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Five Prime Therapeutics Inc$6.12($.29)(4.52%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Five Prime Therapeutics Inc has an overall rank of 2748 out of 7554 stocks based on 10 positive rankings and 7 negative rankings.

Positive Rankings
Up Ratings Revision
During the past month, the average analyst's rating or recommendation has increased. Among companies that have been upgraded within the past month, Five Prime Therapeutics Inc is ranked 98.
10 Day Gain
Five Prime Therapeutics Inc rank is 131
Target Prices
The average analysts' target price is $9.00 for Five Prime Therapeutics Inc using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Five Prime Therapeutics Inc is ranked 204.
Estimated Revenue Growth
Five Prime Therapeutics Inc rank is 519
Highest Cash Growth
Five Prime Therapeutics Inc rank is 599
Low Put/Call
Five Prime Therapeutics Inc has a low Put/Call ratio of 0.24 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Five Prime Therapeutics Inc is ranked 817.
90 Day Gain
Five Prime Therapeutics Inc rank is 857
Debt-to-Equity
Five Prime Therapeutics Inc rank is 1005
Up EPS Surprise
Five Prime Therapeutics Inc beat the consensus earnings estimate when it last reported quarterly earnings.
Price-to-Book
Five Prime Therapeutics Inc rank is 2265
Negative Rankings
Negative Net Margin
Five Prime Therapeutics Inc rank is 246
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Five Prime Therapeutics Inc is ranked 388.
Negative ROE
Five Prime Therapeutics Inc rank is 438
Negative ROA
Five Prime Therapeutics Inc rank is 441
Price-to-Sales
Five Prime Therapeutics Inc rank is 521
Negative Revenue Growth
Five Prime Therapeutics Inc rank is 674
High vPut/Call
Five Prime Therapeutics Inc has a high Put/Call ratio of 0.74 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Five Prime Therapeutics Inc is ranked 1205.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.